Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biochimica Et Biophysica Acta|October 15, 2013
Functional heterogeneity of pulmonary surfactant protein-D in cystic fibrosisSailesh Kotecha, Iolo Doull, Philip Davies, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trialColin Powell, Ruwanthi Kolamunnage-Dona, John Lowe, et al.
International Journal of Technology Assessment in Health Care|November 15, 2014
Economic evaluation of nebulized magnesium sulphate in acute severe asthma in childrenStavros Petrou, Angela Boland, Kamran Khan, et al.
The Lancet. Respiratory Medicine|May 21, 2018
The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trialKatherine Ronchetti, Jo-Dee Tame, Christopher Paisey, et al.
Archives of Disease in Childhood|August 30, 2020
Cystic fibrosis newborn screening: the importance of bloodspot sample qualityIolo Doull, Christopher William Course, Ruth E Hanks, et al.
JAMA Pediatrics|December 13, 2021
Inhaled Corticosteroids Alone and in Combination With Long-Acting β2 Receptor Agonists to Treat Reduced Lung Function in Preterm-Born Children: A Randomized Clinical TrialNia Goulden, Michael Cousins, Kylie Hart, et al.
Biochimica Et Biophysica Acta|May 5, 2010
Inactivation of IL-6 and soluble IL-6 receptor by neutrophil derived serine proteases in cystic fibrosisEamon P McGreal, Philip L Davies, Wendy Powell, et al.
Journal of Clinical Immunology|June 24, 2021
Haematopoietic Stem Cell Transplant for Norovirus-Induced Intestinal Failure in X-linked AgammaglobulinemiaBen M J Shillitoe, Mark Ponsford, Mary A Slatter, et al.
The European Respiratory Journal|December 16, 2017
ERS statement: interventional bronchoscopy in childrenErnst Eber, Juan L Antón-Pacheco, Jacques de Blic, et al.
Molecular Pharmaceutics|February 3, 2016
A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory DiseaseManon F Pritchard, Lydia C Powell, Georgina E Menzies, et al.
Pageof 3